Kymberley Scroggie

Dr. Kymberley Scroggie

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 July 2023 in Digital Discovery
Verified
Journal Article
Open access
PDF file
KSKymberley Scroggie
Kymberley Scroggie
KBKlementine J. Burrell-Sander
Klementine J. Burrell-Sander
Peter RutledgePeter Rutledge
Peter Rutledge
AMAlice Motion
Alice Motion
Sharing scientific experiments and data with the community using GitHub as an electronic laboratory notebook.

11 January 2025 in Next Sustainability
Verified
Journal Article
Open access
KLKatherine E.S. Locock
Katherine E.S. Locock
ATAndrew Terhorst
Andrew Terhorst
SKSarah King
Sarah King
KSKymberley Scroggie
Kymberley Scroggie

YGYaela Naomi Golumbic
Yaela Naomi Golumbic
KSKymberley Scroggie
Kymberley Scroggie
CKCiara R. Kenneally
Ciara R. Kenneally
JLJiarun Lin
Jiarun Lin
MBMitchell Tabrum Blyth
Mitchell Tabrum Blyth
AMAlice Motion
Alice Motion
The World Health Organization (WHO) maintains a list of medicines and medical devices, essential medicines, that should be available to everyone, to form a functioning healthcare system. Yet, many of these medicines remain out of reach for people around the world. One significant barrier to improving the accessibility of essential medicines is a paucity of information about both the extent and causes of this problem. E$$ENTIAL MEDICINE$ (E$$) is a citizen science project designed to investigate this deficit of information by recruiting members of the public to find, validate, compile and share information on essential medicines through an open, online database. Herein, we report an approach to crowdsourcing both the collection of information on the accessibility of essential medicines and the subsequent communication of these findings to diverse audiences. The Meet the Medicines initiative encourages members of the public to share information from the E$$ database, in a short video format appropriate for social media. This communication details the design and implementation of our crowdsourced approach and strategies for recruiting and supporting participants. We discuss data on participant engagement, consider the benefits and challenges of this approach and suggest ways to promote crowdsourcing practices for social and scientific good.

5 May 2025 in ChemRxiv
Verified
Preprint
Open access
PDF file
HDHung Phat Duong
Hung Phat Duong
DMDmitrij Melechov
Dmitrij Melechov
WLWilson Lim
Wilson Lim
JMJingyi Ma
Jingyi Ma
KSKymberley Scroggie
Kymberley Scroggie
MTMatthew Todd
Matthew Todd
The fenarimol analogue EPL-BS1246 was previously discovered to be potent against Madurella mycetomatis, the causative agent of the neglected tropical disease eumycetoma. Further evaluation of a small set of fenarimol analogues in vivo revealed a correlation between efficacy and the lipophilicity (logD) of the analogues. To explore both this correlation and the series structure-activity relationship (SAR), we have evaluated a total of 185 fenarimol analogues derived from five different daughter chemotypes. Potent (MIC50 <9 μM) in vitro activity was found for 22 analogues, five of which gave promising results in an in vivo larval survival assay. Again, a trend towards prolonged larval survival (better in vivo activity) was noted in analogues with logD values <2.5. Insights into the SAR could be gleaned that suggested optimal substituents for the rings forming the fenarimol core.